Director Dealing and Total Voting Rights
Source: RNSIdeagen PLC
("Ideagen," "the Company" or the "Group'')
Director Dealing and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that Ben Dorks, Chief Executive Officer of the Company, has exercised 1,000,000 share options with an exercise price of 22.38 pence each over the ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares" and the "Exercise") and subsequently sold 650,000 Ordinary Shares at a price of 147.50 pence per Ordinary Share (the "Sale").
Following the Exercise and Sale, Mr. Dorks' beneficial interest in Ordinary Shares of the Company has increased by 350,000 to 2,350,533 Ordinary Shares representing 1.06% of the total voting rights of the Company.
Application has been made to the London Stock Exchange for the 1,000,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 23 September 2019.
After Admission, the total number of Ordinary Shares in issue will be 220,818,344 and the total number of voting rights will therefore be 220,818,344. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
The information communicated in this announcement includes inside information for the purposes of Article 7 of Regulation 596/2014
Enquiries:
|
Ideagen plc |
01629 699100 |
|
David Hornsby, Executive Chairman |
|
|
Ben Dorks, Chief Executive |
|
|
Graeme Spenceley, Finance Director |
|
|
|
|
|
finnCap Limited |
020 7220 0500 |
|
Henrik Persson/James Thompson (Nomad) |
|
|
Alice Lane (ECM) |
|
|
Canaccord Genuity |
020 7523 8000 |
|
Simon Bridges |
|
|
Richard Andrews |
|
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.
With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.
Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.
Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.
For further information please visit www.ideagen.com
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Ben Dorks |
||||
|
2. |
Reason for the Notification |
|||||
|
a) |
Position/status |
Chief Executive |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Ideagen plc |
||||
|
b) |
LEI |
213800KS1MLITOVNYC85 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary Shares of 1p each |
||||
|
Identification code |
GB00B0CM0C50 |
|||||
|
b) |
Nature of the transaction |
Exercise of Options over Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information: · Aggregated volume · Price |
1,000,000 options over ordinary shares of 1p each exercised |
||||
|
e) |
Date of the transaction |
16 September 2019 |
||||
|
f) |
Place of the transaction |
London Stock Exchange AIM market (XLON) |
||||
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
|
a) |
Name |
Ben Dorks |
||||||||
|
2. |
Reason for the Notification |
|||||||||
|
a) |
Position/status |
Chief Executive |
||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name |
Ideagen plc |
||||||||
|
b) |
LEI |
213800KS1MLITOVNYC85 |
||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary Shares of 1p each |
||||||||
|
Identification code |
GB00B0CM0C50 |
|||||||||
|
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||
|
d) |
Aggregated information: · Aggregated volume · Price |
650,000 ordinary shares of 1p each sold at 147.5p per ordinary share |
||||||||
|
e) |
Date of the transaction |
16 September 2019 |
||||||||
|
f) |
Place of the transaction |
London Stock Exchange AIM market (XLON) |
||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
